Multivalent, high-relaxivity MRI contrast agents using rigid cysteine-reactive gadolinium complexes - Wikidata - wikimedia - TriplyDB

Multivalent, high-relaxivity MRI contrast agents using rigid cysteine-reactive gadolinium complexes

Multivalent, high-relaxivity MRI contrast agents using rigid cysteine-reactive gadolinium complexes

http://www.wikidata.org/entity/Q35281165

about

Dendritic Polymers for Theranostics Lanthanide probes for bioresponsive imaging Choosing an effective protein bioconjugation strategy Virus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicine Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.Mn-porphyrin conjugated Au nanoshells encapsulating doxorubicin for potential magnetic resonance imaging and light triggered synergistic therapy of cancer Metal Chelating Crosslinkers Form Nanogels with High Chelation Stability.High relaxivity Gd(III)-DNA gold nanostars: investigation of shape effects on proton relaxation.Multivalent viral capsids with internal cargo for fibrin imaging.Enhancing magnetic resonance imaging with contrast agents for ultra-high field strengths Redox-triggered self-assembly of gadolinium-based MRI probes for sensing reducing environment Analytical methods for characterizing magnetic resonance probes.P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents Graphene oxide enhances cellular delivery of hydrophilic small molecules by co-incubation.X-ray spatial frequency heterodyne imaging of protein-based nanobubble contrast agents.Silica microparticles as a solid support for gadolinium phosphonate magnetic resonance imaging contrast agents.Lumazine Synthase Protein Nanoparticle-Gd(III)-DOTA Conjugate as a T1 contrast agent for high-field MRI Reversible Folding of a β-Hairpin Peptide by a Metal-Chelating Amino Acid.Silica-coated Gd(DOTA)-loaded protein nanoparticles enable magnetic resonance imaging of macrophages.Synthetically Modified Viral Capsids as Versatile Carriers for Use in Antibody-Based Cell Targeting.Conjugation to Biocompatible Dendrimers Increases Lanthanide T2 Relaxivity of Hydroxypyridinone (HOPO) Complexes for Magnetic Resonance Imaging (MRI)Multi-Functionality in Theranostic Nanoparticles: is more Always Better?Controlled integration of gold nanoparticles and organic fluorophores using synthetically modified MS2 viral capsids.Cancer Theranostic Nanoparticles Self-Assembled from Amphiphilic Small Molecules with Equilibrium Shift-Induced Renal Clearance.[Gd(CyPic3A)(H2O)2]-: a stable, bis(aquated) and high-relaxivity Gd(III) complex.Design of virus-based nanomaterials for medicine, biotechnology, and energy.Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening.Production and applications of engineered viral capsids.Self-assembled cage-like protein structures.Viral chemistry: the chemical functionalization of viral architectures to create new technology.Substitutional limit of gadolinium in β-tricalcium phosphate and its magnetic resonance imaging characteristics.Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agents Synthesis and chemical reactivity of a 6-Me-3,2-hydroxypyridinone dithiazolide with primary amines: a route to new hexadentate chelators for hard metal(III) ions.A novel method to produce armored double-stranded DNA by encapsulation of MS2 viral capsids.Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza.Osmolyte-mediated encapsulation of proteins inside MS2 viral capsids.PEGylated hybrid ytterbia nanoparticles as high-performance diagnostic probes for in vivo magnetic resonance and X-ray computed tomography imaging with low systemic toxicity.Spherical Polyelectrolyte Brushes as a Novel Platform for Paramagnetic Relaxation Enhancement and Passive Tumor Targeting.Paramagnetic self-assembled nanoparticles as supramolecular MRI contrast agents.Using the dendritic polymer PAMAM to form gold nanoparticles in the protein cage thermosome.

P2860

Q26746182-1B44A589-F7BE-4D93-B968-CB20510C68E2 Q27000361-90B08E8D-25CF-49C5-ACE6-F59C42A07ED6 Q28253030-60ED9F24-A33A-4C62-B625-41766F638912 Q28550482-8F381C1D-EACA-4EDE-9CD1-611463609005 Q30577667-DD22B36D-B216-4B44-9A7E-4AFB5C8EEC9A Q30584584-567F3108-4E61-404C-A4E3-8381C62B8623 Q30751363-77B19C7F-A4B1-46E9-9D91-EBDA6EBE4CEC Q30901328-38AEFE10-17D8-4164-8124-71E3AE69C1B0 Q33800320-AA887E11-C76E-494B-B872-A4CFC6DE3DD5 Q34071930-87077DCA-5207-48DD-B472-5A2686B14CB6 Q34074857-A8DA39DB-EB8E-460A-9AF1-E1603AA1AB0D Q34280357-04A0774A-4884-4452-AFE1-9BE24DA2E038 Q34289410-B28D7C7C-AD61-481C-BE65-9A83D3D0DC5A Q34419918-DEE5FDE6-22FA-43A0-AC34-1D1424BD7724 Q34584613-895A9B13-91C0-4D88-8F43-69075F2B3FC9 Q36112041-0E543622-5D54-4EF4-9AA1-A0BA94B50233 Q36192560-4ACC7AC1-B6F4-4094-831B-C87442877DD2 Q36332528-A89B5063-EE69-4B29-95F6-D2059F5FB1C4 Q36361995-D7643DFB-BBF6-41E6-BB53-E51FD19B8FED Q36592213-50F2D7E8-6187-49F3-84BC-A1F41C3B615A Q36714422-148A48CC-6A1E-4B16-9F35-23D4016815D4 Q36737255-9794D588-65D0-4B78-B8A2-FCE71CCD0660 Q36763808-3908AE47-0A0B-4EDA-9243-A9A3041CAE99 Q37112982-212046D8-1F8E-48AF-8698-3D2CE8D79DE1 Q37218029-1D908E3C-FD94-4A17-A202-0B12703D761D Q37346447-F7909C31-676C-41EF-B152-75EB482A186E Q38155457-27E90A39-D29B-406B-9D44-40DDB7DAA57F Q38210894-A95A5E79-4FA1-4D15-BF3D-F49878DDF0E4 Q38339875-F8A5C6D1-1A97-4E64-A2AE-FFF9BDC23C9E Q38668484-B3136046-2349-46A2-B25C-96C5EAC7F165 Q39334259-4A010630-96E5-4DDF-BE7E-75EAAD590AF0 Q39804161-A06B35DD-D5F6-475B-AEAF-E0A86799AFBB Q41130080-590FFB3A-911B-48E0-9A6A-CF55CF305700 Q41733472-F3C9F401-A79D-4EF1-BFF9-F839E5B310A1 Q41942589-D647EA10-ADB3-4A1D-92A3-36F3C1477361 Q42408480-7F6698C0-A31B-4002-86D7-F7B0046DF1B8 Q43828825-AE076E15-111E-417D-B7EF-993F0D0CC4FA Q48328381-CD6A8892-2824-4FC5-8676-E1CA83C53E01 Q48545737-BA7C9CBA-73CD-4CD9-A8D7-A8341F849EF9 Q51216164-8A9DEB91-6EEE-49F5-8463-FF7847811D30

P2860

Multivalent, high-relaxivity MRI contrast agents using rigid cysteine-reactive gadolinium complexes

http://www.wikidata.org/entity/Q35281165

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Multivalent, high-relaxivity M ...... -reactive gadolinium complexes

@ast

Multivalent, high-relaxivity M ...... -reactive gadolinium complexes

@en

type

label

Multivalent, high-relaxivity M ...... -reactive gadolinium complexes

@ast

Multivalent, high-relaxivity M ...... -reactive gadolinium complexes

@en

prefLabel

Multivalent, high-relaxivity M ...... -reactive gadolinium complexes

@ast

Multivalent, high-relaxivity M ...... -reactive gadolinium complexes

@en

P1433

Q35281165-0542C7CE-D7BE-4A4E-B28F-EC3762FA3CEE

P1476

Q35281165-1A01282A-1B15-4335-ADD5-BE740F4F1494

P2093

Q35281165-9495492E-C980-4C2D-9F1B-7797ABD73599

Q35281165-DAF942A3-41B4-476C-AAC6-44DD1E5A195E

Q35281165-E6F647FA-7D2E-4FC6-A639-104D73203A0E

Q35281165-F255C857-61F8-4566-8D02-684ABA5C98A9

Q35281165-FD10C998-529A-428A-A7E3-CE0D7207854C

P2860

Q35281165-0077496D-6C15-48AA-8FE2-0F87730B43BE

Q35281165-00ED51CB-44CC-4C3C-AEDD-ECDF628B82BB

Q35281165-12BF5451-5B83-49C7-A1C2-83CFEC06B6EA

Q35281165-1523B936-915A-4733-B68B-303A4DEA4D6F

Q35281165-15423F44-BB5B-4D00-BBA7-FCD6266DD3A2

Q35281165-3C4A9434-1921-44DC-B689-DED1F398B006

Q35281165-41578ACE-C3E8-4E40-BCEA-4C4CD89A8F30

Q35281165-43FADECB-9B4E-4A24-B042-03B06689FD8A

Q35281165-445EDBC1-BBB1-4E1E-AA28-B70DEAE441E6

Q35281165-455F870A-5CE2-4397-87B5-CC077C160774

P304

Q35281165-212DA9B4-0A10-4D40-BC47-FF411FAD508A

P31

Q35281165-AB8CA6B9-9CF9-4B1E-BD73-C061905478D3

P356

Q35281165-A08BB420-04E6-4EB7-93CB-0B985CAF8ECD

P407

Q35281165-D9E9FB3E-5896-4196-A65B-7706D3A17BCF

P433

Q35281165-520027DA-554E-43C8-B2BA-86FA58A67907

P478

Q35281165-79AF7F17-AC99-4808-8865-403162808336

P577

Q35281165-37249AB5-3E28-42AE-8D20-746CC75C7403

P5875

Q35281165-022E7590-795A-4498-A58E-98BBE0194DB3

P698

Q35281165-9238011A-58EA-43CD-874A-7E167BD97CCF

P932

Q35281165-FF7B1ED9-451D-468C-8055-196207876415

P356

P1433

Journal of the American Chemical Society

P1476

Multivalent, high-relaxivity M ...... -reactive gadolinium complexes

@en

P2093

Ankona Datta

http://www.w3.org/2001/XMLSchema#string

Dante W Romanini

http://www.w3.org/2001/XMLSchema#string

Kenneth N Raymond

http://www.w3.org/2001/XMLSchema#string

Matthew B Francis

http://www.w3.org/2001/XMLSchema#string

Praveena D Garimella

http://www.w3.org/2001/XMLSchema#string

P2860

Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications

A highly stable gadolinium complex with a fast, associative mechanism of water exchange.

Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.

Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent.

Dendrimeric gadolinium chelate with fast water exchange and high relaxivity at high magnetic field strength.

Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.

Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents.

Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.

Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules.

High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: nanosized MRI contrast agents.

P304

14704-14709

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JA204516P

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51532200

http://www.w3.org/2001/XMLSchema#string

P698

21800868

http://www.w3.org/2001/XMLSchema#string

P932

3188312

http://www.w3.org/2001/XMLSchema#string